Close
Xylem
Novotech

News

Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna’s COVID-19 Vaccine

Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Therapeutic Goods Administration (TGA) has granted provisional registration to the COVID-19 Vaccine Moderna in Australia for active immunization to prevent COVID-19 caused by SARS-CoV-2...

Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership

Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC) CRO Best Practices Award for the company from Frost...

Johnson & Johnson’s single-dose COVID-19 vaccine gets approval for emergency use in India

Johnson & Johnsonโ€™s (J&J) single-dose Covid-19 vaccine was on Saturday granted approval for emergency use in India. โ€œIndia expands its vaccine basket. Johnson and Johnsonโ€™s single-dose Covid-19 vaccine is given approval for Emergency Use in India,โ€ health minister Mansukh...

Inovio, Advaccine receive regulatory nod for two heterologous prime-boost trials in China using Covid-19 DNA vaccine candidate, INO-4800

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced that it has received regulatory allowance for two clinical trials investigating heterologous boosting...

Seagen and RemeGen enter up to $2.6bn deal for cancer drug

Seagen and a Chinese company, RemeGen, have signed an exclusive global licencing agreement to develop and market a new HER2-targeted antibody-drug conjugate (ADC), disitamab vedotin. Merging Seagenโ€™s drug-linker technology with RemeGenโ€™s new HER2 antibody, disitamab vedotin selectively carries the anti-cancer...

Sharp Appoints New Business Development Manager for UK Commercial Services

Sharp, a part of UDG Healthcare and a leading provider of pharmaceutical packaging and clinical services, has appointed Paul Thomas as Business Development Manager for its UK commercial services. Reporting to Jeff Benedict, Chief Commercial Officer at Sharp, Paul has...

DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients

DFE Pharma, a global leader in pharmaceutical excipient solutions, is continuously supporting relevant scientific research and innovations in its field. With the recent publication of a new study demonstrating the impact of powder properties on the rheological behavior of excipients,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป